Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carfilzomib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02145403
What this trial is testing

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesRelapseGraft-Versus-Host Disease
University of Michigan Rogel Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756896
What this trial is testing

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Emory University 29
Early research (Phase 1)Ended earlyNCT02269085
What this trial is testing

Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 8
Early research (Phase 1)Active Not RecruitingNCT03798678
What this trial is testing

CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT01690143
What this trial is testing

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 45
Testing effectiveness (Phase 2)Study completedNCT02073097
What this trial is testing

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Large Cell Lymphoma+2 more
Case Comprehensive Cancer Center 48
Early research (Phase 1)Study completedNCT01276717
What this trial is testing

Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma

Who this might be right for
Lymphoma
University of Rochester 20
Testing effectiveness (Phase 2)UnknownNCT05509374
What this trial is testing

Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone

Who this might be right for
Multiple Myeloma
Samsung Medical Center 33
Not applicableUnknownNCT05495620
What this trial is testing

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Dong-A University Hospital 300
Early research (Phase 1)UnknownNCT01991301
What this trial is testing

Carfilzomib for the Prevention of Graft Versus Host Disease

Who this might be right for
Graft-versus-host Disease
Sheba Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07348393
What this trial is testing

A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)
Assistance Publique - Hôpitaux de Paris 70
Not applicableEnded earlyNCT04827563
What this trial is testing

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Who this might be right for
Multiple MyelomaShortness of BreathDyspnea+1 more
University of Chicago 50
Post-approval studies (Phase 4)Study completedNCT03934684
What this trial is testing

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
Amgen 101
Not applicableNot Yet RecruitingNCT07015021
What this trial is testing

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

Who this might be right for
Multiple MyelomaCarfilzomibDaratumumab+1 more
The First Affiliated Hospital of Soochow University 72
Testing effectiveness (Phase 2)Study completedNCT03224507
What this trial is testing

Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 123
Early research (Phase 1)Study completedNCT03605719
What this trial is testing

Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Emory University 23
Testing effectiveness (Phase 2)Study completedNCT02891811
What this trial is testing

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Testing effectiveness (Phase 2)Looking for participantsNCT04661137
What this trial is testing

Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 96
Testing effectiveness (Phase 2)Study completedNCT02969837
What this trial is testing

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 46
Testing effectiveness (Phase 2)Study completedNCT02203643
What this trial is testing

Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Who this might be right for
MULTIPLE MYELOMA (MM)
Mario Boccadoro 477
Next Page